BCL2 protein expression in DLBCL can be caused by different genetic events such as translocations, mutations, gains, and amplifications as well as transcriptional upregulation from pathways discussed later (BCR signaling and NF-kB) (Table 2) [31]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.